Q32 Bio (QTTB) Return on Sales (2018 - 2024)
Historic Return on Sales for Q32 Bio (QTTB) over the last 7 years, with Q3 2024 value amounting to 43.47%.
- Q32 Bio's Return on Sales rose 509500.0% to 43.47% in Q3 2024 from the same period last year, while for Sep 2024 it was 43.47%, marking a year-over-year increase of 504000.0%. This contributed to the annual value of 8.08% for FY2023, which is 82300.0% down from last year.
- Per Q32 Bio's latest filing, its Return on Sales stood at 43.47% for Q3 2024, which was up 509500.0% from 111.07% recorded in Q2 2024.
- Q32 Bio's Return on Sales' 5-year high stood at 115.54% during Q1 2022, with a 5-year trough of 111.07% in Q2 2024.
- For the 5-year period, Q32 Bio's Return on Sales averaged around 18.43%, with its median value being 18.25% (2021).
- As far as peak fluctuations go, Q32 Bio's Return on Sales skyrocketed by 1155800bps in 2022, and later plummeted by -1178600bps in 2023.
- Over the past 5 years, Q32 Bio's Return on Sales (Quarter) stood at 30.4% in 2020, then tumbled by -38bps to 41.87% in 2021, then fell by -3bps to 43.1% in 2022, then soared by 146bps to 20.0% in 2023, then soared by 117bps to 43.47% in 2024.
- Its last three reported values are 43.47% in Q3 2024, 111.07% for Q2 2024, and 12.34% during Q1 2024.